Understanding the Diversity of Pharmacotherapeutic Management of ADHD With Co-occurring Autism: An Australian Cross-Sectional Survey
ObjectivesAttention deficit hyperactivity disorder (ADHD) frequently co-occurs with other neurodevelopmental diagnoses, such as autism spectrum disorder (autism), which can make clinical decision making around symptom management challenging for clinicians. There is a paucity of research examining ph...
Main Authors: | Olivia J. Mellahn, Rachael Knott, Jeggan Tiego, Kathryn Kallady, Katrina Williams, Mark A. Bellgrove, Beth P. Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.914668/full |
Similar Items
-
The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
by: Rafał Bieś, et al.
Published: (2023-09-01) -
Effectiveness of Psychostimulant and Non-Psychostimulant Drug Therapy in the Attention Deficit Hyperactivity Disorder
by: Adriana Cojocaru, et al.
Published: (2021-01-01) -
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
by: Daniela Senior, et al.
Published: (2023-03-01) -
Role of environmental enrichment on social interaction, anxiety, locomotion, and memory in Wistar rats under chronic methylphenidate intake
by: Laura Herrera-Isaza, et al.
Published: (2023-11-01) -
Efficacy and tolerability of psychostimulants for symptoms of attention-deficit hyperactivity disorder in preschool children: A systematic review and meta-analysis
by: Hsien-Jane Chiu, et al.
Published: (2023-01-01)